These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8136931)

  • 1. Calcium antagonists in the management of systemic hypertension: the impact of sustained-release drug-delivery systems.
    Frishman WH; Rosenberg A; Katz B
    Coron Artery Dis; 1994 Jan; 5(1):4-13. PubMed ID: 8136931
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium antagonists in cardiology: update on sustained-release drug delivery systems.
    Michelson EL
    Clin Cardiol; 1991 Dec; 14(12):947-50. PubMed ID: 1841019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockers: summary and safety issues.
    Opie LH
    Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():893-5. PubMed ID: 9126679
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug preparations of calcium channel blockers].
    Warnke A; Blume H
    Pharm Unserer Zeit; 2005; 34(5):400-10. PubMed ID: 16180363
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcium channel blockers in systemic hypertension.
    Frishman WH; Charlap S; Michelson EL
    Am J Cardiol; 1986 Jul; 58(1):157-60. PubMed ID: 3524178
    [No Abstract]   [Full Text] [Related]  

  • 6. Nifedipine in ischemic heart disease.
    Kloner RA
    Circulation; 1995 Sep; 92(5):1074-8. PubMed ID: 7648647
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current controversies concerning the use of calcium antagonists].
    Rossi G
    Recenti Prog Med; 1996 Mar; 87(3):114-7. PubMed ID: 8650431
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium-channel antagonists.
    Gemmill J
    Practitioner; 1993 Aug; 237(1529):638-40. PubMed ID: 8255861
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcium channel blockers and hypertension: evolving perspective--1996.
    Epstein M
    Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():883-91. PubMed ID: 9126678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Slow release nifedipine in treatment of hypertension. 24-hour effect on blood pressure and heart rate--treatment follow-up of 391 patients].
    Bühler G; Wadepuhl M; Nandi K; Rosenthal J
    Fortschr Med; 1997 Aug; 115(24):37-8. PubMed ID: 9410819
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment with nifedipine retard: increasing doses as a therapeutic method].
    Lobos Berajano JM; Lahoz Rallo F; Seguido Aliaga P; Castellanos Maroto J; Robles Pérez R
    Rev Clin Esp; 1989 Jan; 184(1):47-9. PubMed ID: 2704870
    [No Abstract]   [Full Text] [Related]  

  • 12. [Verapamil-associated liver injury].
    Odeh M; Oliven A
    Harefuah; 1998 Jan; 134(1):36-7. PubMed ID: 9517278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained-release calcium channel antagonists in cardiovascular disease: pharmacology and current therapeutic use.
    Silvestry FE; St John Sutton MG
    Eur Heart J; 1998 Aug; 19 Suppl I():I8-14. PubMed ID: 9743438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained-release diltiazem overdose.
    Morimoto S; Sasaki S; Kiyama M; Hatta T; Moriguchi J; Miki S; Kawa T; Nakamura K; Itoh H; Nakata T; Takeda K; Nakagawa M
    J Hum Hypertens; 1999 Sep; 13(9):643-4. PubMed ID: 10482975
    [No Abstract]   [Full Text] [Related]  

  • 15. [Differences in the bioavailability of delayed action and standard preparations of calcium antagonists].
    Blume H
    Internist (Berl); 1994 Aug; 35(8):782-3. PubMed ID: 7960558
    [No Abstract]   [Full Text] [Related]  

  • 16. [Innovation, step innovation, Me too. Are calcium antagonists interchangeable?].
    MMW Fortschr Med; 2001 Dec; 143(51-52):53. PubMed ID: 11824171
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation?
    Yusuf S
    Circulation; 1995 Sep; 92(5):1079-82. PubMed ID: 7648648
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose initiation of calcium antagonists in the treatment of hypertension.
    Müller FB; Erne P; Hotz M; Bolli P; Follath F; Bühler FR
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):118S-124S. PubMed ID: 3794763
    [No Abstract]   [Full Text] [Related]  

  • 19. [Calcium antagonists and hypertension: in search of absolute certainty].
    Mayer G
    Wien Klin Wochenschr; 1998 Oct; 110(18):621-4. PubMed ID: 9816633
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of calcium antagonists on sympathetic activity.
    Grossman E; Messerli FH
    Eur Heart J; 1998 Jun; 19 Suppl F():F27-31. PubMed ID: 9651732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.